MBX Biosciences, Inc. (MBX) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mbx Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.415 -- 00:00:03.880 Good morning, everyone. Thanks for joining us today. 00:00:03.880 -- 00:00:08.830 We have a session with Microbix to discuss the Q2 results they put out this morning. 00:00:08.830 -- 00:00:13.920 You can find those on the company's website on CDAR and the press release probably was 00:00:13.920 -- 00:00:19.296 sent to your inbox, let's hope. So with me today, I've got Ken 00:00:19.296 -- 00:00:23.804 Hughes, COO, Jim Curry, CFO, and Cameron Groom, CEO. 00:00:23.804 -- 00:00:28.211 The format of the session will be a review of the quarterly results by Cameron and his 00:00:28.211 -- 00:00:32.559 team, and then we'll open it up for Q&A. So feel free to start putting your questions 00:00:32.559 -- 00:00:35.223 in the Q&A box if you'd like, or you can email them to me. 00:00:35.223 -- 00:00:39.417 I don't believe that we're going to work off a formal presentation today. 00:00:39.417 -- 00:00:42.400 But as always, this session will contain forward-looking statements. 00:00:42.400 -- 00:00:47.565 You can find more about those on the company's website, on the presentation on the website, 00:00:47.565 -- 00:00:50.507 which I will update later today with the results. 00:00:50.507 -- 00:00:55.212 And with that out of the way, I'd like to turn the mic over to Cameron Groom, CEO. 00:00:55.212 -- 00:00:57.472 Hi, Cameron. 00:00:57.874 -- 00:01:01.538 Hello, Debra. I'll start by taking myself off mute. 00:01:01.538 -- 00:01:04.661 It's always a good start for these things. 00:01:04.661 -- 00:01:07.548 Thank you very much, Debra. 00:01:07.548 -- 00:01:12.134 and Jim and Ken for joining us and for Second Deborah as well. 00:01:12.134 -- 00:01:14.134 And 00:01:14.658 -- 00:01:18.683 thank you to everyone participating for 00:01:18.683 -- 00:01:23.3...